Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin Lymphoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- Neil Josephson, MD
Seagen Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
13 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- University of Alabama at Birmingham
Birmingham, Alabama, United States
- Pacific Hematology Oncology Associates
San Francisco, California, United States
- Stanford Cancer Center
Stanford, California, United States
- Oncology Institute of Hope & Innovation, the
Whittier, California, United States
- Colorado Blood Cancer Institute
Denver, Colorado, United States
- Dana Farber Cancer Institute
Boston, Massachusetts, United States
- Mayo Clinic Minnesota
Rochester, Minnesota, United States
- University of Nebraska Medical Center
Omaha, Nebraska, United States
- Columbia University Medical Center
New York, New York, United States
- Jewish Hospital, the
Cincinnati, Ohio, United States
- Case Western Reserve University / University Hospitals Case Medical Center
Cleveland, Ohio, United States
- Saint Francis Hospital / Bon Secours
Greenville, South Carolina, United States
- Charles A. Sammons Cancer Center / Baylor University Medical Center
Dallas, Texas, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 30 Jun 2013
- Primary completion
- 31 Dec 2015
- Completion
- 20 Feb 2018
- Last update posted
- 12 Feb 2019
- Registered enrollment
- 55
- Registry id
- NCT01874054
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.